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Abstract 
 
In the present work, the first characterizations by Capillary Electrophoresis of the human 
Chorionic Gonadotropin (hCG) hormone at the intact level were carried out. hCG is a hetero-
dimeric glycoprotein, specific to the human pregnancy, consisting of an α and a β subunit, so-
called hCGα and hCGβ, respectively. hCG has 8 potential glycosylation sites leading to a 
high number of isoforms (including glycoforms and other post-translational modifications) 
that we are interesting to characterize. First, Capillary Gel Electrophoresis (CGE) was used to 
separate the isoforms of two hCG-based drugs: Ovitrelle® (recombinant r-hCG) and Pregnyl 
(hCG isolated from the urine of pregnant women, u-hCG). As expected, CGE led to a better 
resolution than SDS-PAGE and confirmed the large heterogeneity of hCG. Different CGE 
profiles were obtained for the two hCG-based drugs, varying in number of peaks, migration 
times, and peak intensities, thus demonstrating that the drugs contain isoforms, different in 
nature and proportion. This result was confirmed by Capillary IsoElectrophoretic Focusing 
(CIEF). The pI ranges of the hCG isoforms were found between 3.4 and 4.7, and 4.5 and 5.2 
for r-hCG and u-hCG, respectively. This information was further used to develop the 
separation of the hCG isoforms by Capillary Zone Electrophoresis (CZE). The pH, the nature, 
and the concentration of the background electrolyte as well as the nature and the content of its 
organic modifier were optimized. The use of a coated capillary to avoid protein adsorption 
was also evaluated. The final CZE-UV method allowed distinguishing at least 6 peaks, 
corresponding to different hCG isoforms.   
To significantly improve the level of information obtained, the CZE instrument was then 
coupled by means of an electrospray ionization source to a triple quadrupole (TQ) mass 
spectrometer. Two detection strategies were used, one focusing on the lower m/z values (100-
1000) in order to identify some sugar residues as diagnostic ions to confirm the presence of 
glycan chains, and the second focusing on the higher m/z values (1000-2000), corresponding 
to the multiple charged intact protein isoforms. For both approaches, the fragmentor and 
capillary voltage values were optimized. The composition and the flow-rate of the sheath 
liquid were then optimized for the strategy focusing on the higher m/z values in order to both 
increase the charge state of the ionized intact isoforms and the signal-to-noise ratio. The final 
method was used to compare the two hCG-based drugs, demonstrating the potential of the 
developed CZE-MS method for isoforms fingerprinting. 
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1. Introduction 
 
The human Chorionic Gonadotropin (hCG) protein is a hormone essential for the maintenance 
of the pregnancy and the development of both placenta and fetus [1]. hCG is a hetero-dimeric 
glycoprotein consisting of an α and β subunit with a total of eight potential glycosylation 
sites, comprising 4 N- and 4 O-linked oligosaccharides. Its subunits, hCGα and hCGβ, are 
non-covalently associated and internally stabilized by a cysteine knot and disulfide bonds. 
The α-subunit is similar to other gonadotropin hormones, such as the luteinizing hormone 
(LH), the follicle-stimulating hormone (FSH), and the thyroid-stimulating hormone (TSH), 
while the β-subunit constitutes the specific part of the hCG [2]. hCGα has a molecular weight 
(MW) of 10,188 Da with 92 amino acids. Two asparagine-linked carbohydrate units (N-
glycans) were determined on Asn-76 and Asn-102 residues [3,4]. hCGβ is composed of 145 
amino acids and has a MW of 15,509 Da with two asparagine-linked glycans localized on 
Asn-33 and Asn-50 residues. Moreover, four serine-linked oligosaccharides (O-glycans) 
attached to serine residues 121, 127, 132, and 138 have also been shown [5]. With eight 
potential glycans, hCG is a highly glycosylated protein and about 30% of its MW is due to the 
glycosylation [6]. Indeed, its mass range was estimated between 30 and 50 kDa. 
Glycosylation is a commonly observed post-translational modification (PTM) of proteins. 
Indeed, more than 70% of the human proteins are glycosylated [7]. Studies demonstrated that 
the glycosylated state of a protein impacts directly its biological functions, its stability, its 
half-life, etc [3]. Concerning hCG, studies demonstrated that different hCG glycoforms are 
produced by two distinct placental sources and that the glycan profile varies for each source 
of production during the pregnancy [3,8]. Based on these considerations, some glycosylated 
forms of hCG could be potential biomarkers to diagnose pregnancy pathologies from 
placental origin, which represents a major societal challenge.  
Nevertheless, the full characterization of a glycoprotein is very complex due to the high 
number of isoforms, especially for hCG and its 8 glycosylation sites, which can give a very 
large number of glycoforms. Furthermore, other PTMs such as deamidation or oxidation may 
further complicate its characterization. Generally, the glycoprotein characterization is 
currently performed with the analysis of the peptides obtained after the enzymatic digestion of 
the protein, the so-called bottom-up strategy [9–11]. The peptides are separated by liquid 
chromatography (LC) or capillary electrophoresis (CE) prior to their identification by mass 
spectrometry (MS). This strategy allows the identification of proteins, the localization of the 
glycans along the protein chain and the determination of the MW of the glycans [12,13]. 
Concerning hCG, different studies using the bottom-up strategy allowed the sequencing of 
several N-glycopeptides with the composition of the associated glycans for each N-
glycosylation site [14–16]. Furthermore, the interest of the use of a pronase as enzyme to 
isolate the O-glycosylation sites in order to determine the O-glycan composition of the β-
subunit was also demonstrated [17]. Other studies on the hCG showed the interest of a second 
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approach based on the release of the N-glycans after an enzymatic digestion with PNGase-F 
to obtain the N-glycan profiling of different hCG-based drugs [18]. However, despite the 
interest of the bottom-up and released N-glycans approaches to elucidate the composition, the 
structure and the localisation of glycans on the protein, the information on the exact 
combinations of multiple PTMs (macro-heterogeneity) is lost. Moreover, these approaches 
suffer from some disadvantages because of the numerous steps that are usually necessary such 
as alkylation and reduction in addition to enzymatic digestion that are expensive, time 
consuming, and may lead to the loss of some monosaccharides or minority isoforms. 
This is why, currently, the analysis of the proteins at the intact level generates a large interest 
in the field of protein analysis [19, 20]. For hCG, composed of two subunits that both 
contribute to its bioactivity, it may also allow knowing which isoform of hCGα is associated 
with such isoform of hCGβ. Nevertheless, a high performance separation step is required 
because of the structural similarity of the isoforms, in order to reach the best possible 
separation resolution between the isoforms to facilitate their ionization in MS [21].  
Both LC and CE are high-performance separation techniques and are used for the analysis of 
intact proteins [22–25]. We recently published the first characterization of hCG at the intact 
level by reversed-phase liquid chromatography (RPLC) coupled with high-resolution mass 
spectrometry (HRMS) [26]. Nevertheless, only the main isoforms of hCGα were detected 
with this method. As LC and CE are based on different separation mechanisms, capillary 
electrophoresis can provide complementary information to the LC method. Moreover, CE is 
characterized by high efficiencies, especially with proteins since they have a low diffusion 
coefficient, involves aqueous conditions, which allow avoiding the conformational change 
due to a stationary phase, and can separate the protein isoforms as a function of their charge-
to-size ratio, their pI values or their size depending on the involved mechanism.  
The analysis of intact hCG or its subunits by electrokinetic techniques was mainly carried out 
at the non-miniaturized scale, i.e. SDS-PAGE or isoelectric focusing [27–30]. These 
approaches require the use of toxic products, show a long analysis times, use expensive 
materials, high sample volumes while the separation resolution is low [31]. This is why the 
use of electrokinetic methods at the capillary format is nowadays preferred, allowing fast 
analysis thanks to the possibility to apply electric fields 10 to 100 times higher without joule 
effect, leading to a high resolution for the separation of protein isoforms whatever separation 
mode used [22, 23, 32–34].  
As far as we know, the capillary gel electrophoresis (CGE) and the capillary isoelectric 
focusing (CIEF) modes have never been used for the hCG characterization. Concerning 
capillary zone electrophoresis (CZE), three papers were published for hCG, all involving a 
non-volatile borate- or phosphate-based buffer and UV detection, thus preventing any 
identification [34–36]. To go further in the hCG isoform characterization, the hyphenation of 
the CZE separation with mass spectrometry is required. Indeed, the glycoform profiling of the 
intact alpha subunit (hCGα) was done by CZE coupled with a high resolution MS analyser 
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[37]. Hence, this work presents for the first time the analysis of dimeric hCG by CGE, CIEF, 
and CZE-MS. Two hCG-based drugs were used as standards: Ovitrelle® (recombinant hCG, 
r-hCG) and Pregnyl® (hCG from urine of pregnant women, u-hCG).  
 
2. Material and methods 
2.1. Reagents and analytes 
Acetonitrile (ACN), isopropanol (IPA) and methanol (MeOH) were of HPLC grade. 1 M 
NaOH and 0.1 M HCl solutions were purchased from VWR (Fontenay-sous-bois, France). 
Bovine serum albumin (BSA, molecular mass, 66,000 Da), dimethylformamide (DMF, > 
99%), hydroxypropyl cellulose (HPC, molecular mass, 100,000 > 99%), polyvinyl alcohol 
(PVA, molecular mass, 205,000 > 99%), phosphoric acid (85%), arginine, iminodiacetic acid, 
urea, β-mercaptoethanol, and HPLC acetone were purchased from Sigma-Aldrich (Saint-
Quentin-Fallavier, France). Hydrochloric acid (HCl), formic acid (FA), and acetic acid (AC) 
were obtained from Carlo Erba (Val de Reuil, France). The ultra-pure water was obtained 
with a Direct-Q3 UV system (Millipore, Molsheim, France) and used for the preparation of all 
stock solutions and the background electrolyte (BGE).  
Ovitrelle® and Pregnyl®, two hCG-based drugs, were used as recombinant hCG (r-hCG) and 
urinary hCG (u-hCG) standards, respectively. Ovitrelle® (Serono Europe, London, UK) was 
available as a solution containing 250 µg of r-hCG, and Pregnyl (Organon, Oss, The 
Netherlands) as a lyophilized powder containing 5000 IU of u-hCG (1 IU being equivalent to 
a concentration of 0.092 µg L
-1 
[38]). A lyophilized powder, containing 500 µg of r-hCGβ 
(recombinant Pichia pastoris, r-hCGβ), was purchased from Sigma-Aldrich (Saint-Quentin 
Fallavier, France). The Ovitrelle® solution was diluted in water to obtain a stock solution 
containing 100 mg L
-1 
of r-hCG. For Pregnyl® and r-hCGβ, the lyophilized content of each 
ampoule was reconstituted in water at a concentration of 100 mg L
-1
. The standard solutions 
were aliquoted and stored at -20°C. Before the analysis in CZE-MS system, the hCG fractions 
were cleaned and concentrated by centrifugation with ultra-centrifugal units (Merck, 
Darmstadt, Germany) with a molecular weight cut-off of 10 kDa, to remove small additives 
from drug formulations.  
 
2.2  Experimental set-up 
2.2.1 CGE-UV method 
The capillary gel electrophoresis method was carried out using a Beckman P/ACE MDQ 
capillary electrophoresis system (AB Sciex, Ulis, France) equipped with a diode array 
detector (DAD). The detection was performed at 220 nm ± 10 nm, the reference wavelength 
was 350 nm ± 10 nm and the data acquisition rate 2 Hz. The acquisitions were performed by 
the 32 Karat
®
 software version 9.1 (Beckman-Coulter). The separation was achieved using a 
bare fused-silica capillary (Photonlines, Marly-le-Roi, France) with an inner diameter of 
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50 µm, an effective length of 20 cm and a total length of 30.2 cm, installed into a PA 800 
cartridge. The temperature cartridge was set at 25°C. The analysis of the hCG protein was 
performed with the SDS-MW Analysis Kit, delivered by Beckman
®
, that was designed for the 
separation of protein-SDS complexes using a replaceable gel matrix. The kit utilises different 
reagents: ProteomLab SDS-MW sample buffer (100 mM Tris-HCl, 1% SDS, pH 9) and SDS-
MW gel buffer. The SDS-MW size standard (recombinant proteins, 10-225 kDa, supplied 
with the ProteomeLAB
TM
 SDS-Analysis Kit) was used to estimate the protein molecular 
weight. The bovine serum albumin (BSA, 66 kDa) was used as an internal standard (1 µg ml
-1 
in
 
H2O, 2.5 µL in sample). β-mercaptoethanol (5 µL) was also added to each vial, containing 
95 µL of protein sample (10 µl in 85 µl of sample buffer) or diluted SDS-MW size standard. 
Then, the vials were capped tightly and heated at 100°C for 3 min. Prior to the CE analysis, a 
capillary preconditioning was performed by consecutively rinsing the capillary with 1 M 
NaOH (10 min, 20 psi), 0.1 M HCl (5 min, 20 psi), ultra-pure water (2 min, 20 psi), and SDS 
gel (10 min, 70 psi) before the application of a voltage with reverse polarity (-15 kV, 10 min) 
for SDS gel equilibration. Then, the hCG sample was injected electrokinetically (-5 kV, 20 s) 
at a concentration of 2 mg ml
-1
 in H2O. The applied voltage during the separation was set at -
15 kV during 30 min. 
 
 2.2.2 CIEF-UV method 
CIEF experiments were performed on an Agilent G7100 (Agilent Technologies, Massy, 
France) instrument, equipped with a DAD, using a bare fused-silica capillary coated with 
HPC with a total length of 30.2 cm (effective length: 20 cm) x 50 µm inner diameter. The 
detection was performed at 214 nm ± 4 nm and the reference wavelength was 360 nm ± 
100 nm. The data acquisition was 10 Hz and the temperature 25°C. The electropherograms 
were processed by means of the 3D-CE Chemstation software (Agilent Technologies). The 
analysis of hCG was performed using the CIEF kit delivered by Beckman
®
. The kit utilises 
200 mM phosphoric acid as anolyte and 300 mM NaOH as catholyte. The cathodic and 
anodic stabilizers were 500 mM arginine and 200 mM iminodiacetic acid, respectively. The 
chemical mobilizer used was 350 mM acetic acid and the ampholytes provided a pH gradient 
between 3 and 10. The used peptidic pI markers had pI values of 10, 9.5, 7, and 5.5. The CIEF 
gel contained 6 M urea while the rinsing urea solution had a concentration of 4.3 M. The 
applied voltages during focusing and mobilization were set at 25 and 30 kV under normal 
polarity, respectively. The sample consisted of 500 µg ml
-1
 of r-hCG in H2O. 
For the HPC coating, a polymer solution was prepared by dissolving at 40°C HPC in water at 
a concentration of 5% w/v. The procedure was according to Shen and Smith’s protocol [39], 
based on a physical adsorption of highly-hydrophilic substitute-celluloses onto the silica wall 
by a thermal process. For this purpose, the capillary was first pre-treated with acetone during 
10 min, and then washed with 1 M NaOH for 30 min and with 0.1 M HCl and ultra-pure 
water for 10 min each. The polymer solution was then hydrodynamically pumped for 5 min 
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through the capillary at approximately 1 bar. Then, the capillary was put in a gas 
chromatograph oven 3800 GC (Varian, Grenoble, France), heated from 60 to 140°C at 
5°C min
-1
, and held at 140°C for 20 min with a nitrogen flow.  
To evaluate the quality of the coating, the EOF was measured according to the Vigh’s 
procedure [40]. The electroosmotic mobility determination was achieved as follows: (i) the 
capillary was filled with a BGE composed of 5 mM sodium phosphate at pH 7.0, (ii) a neutral 
marker plug (1% DMF, here), diluted in the BGE, was hydrodynamically introduced into the 
capillary, (iii) the DMF plug was moved by pressure, with the capillary inlet introduced in a 
vial containing BGE, (iv) another plug of DMF was hydrodynamically injected and also 
moved by pressure, with the capillary inlet introduced in a vial containing BGE, (v) a voltage 
of 15 kV was applied during 3 min in order to move both DMF bands with electroosmotic 
velocity toward the UV detector, (vi) a third plug of DMF was hydrodynamically introduced 
into the capillary, and finally (vii) a constant pressure was applied, with the capillary inlet 
introduced in a vial containing BGE until CE software recorded the passage of the three plugs 
of DMF (neutral marker) through the detection window. The capillaries having electroosmotic 
mobility values superior to 2 x 10
-5
 cm
2
 V
-1
 s
-1 
were discarded. 
 
2.2.3 CZE-UV method 
The CZE-UV experiments were carried out with an Agilent G7100 instrument. The detection 
was performed at 214 nm ± 4 nm and the reference wavelength was 360 nm ± 100 nm. A 
fused silica capillary with an internal diameter of 50 µm and a total length of 60 cm (effective 
length: 51.5 cm) was used. The applied voltage was + 30 kV with the optimized BGE; no 
joule heating was observed and the generated current was 32 µA. The capillary temperature 
was kept at 60°C. Prior to the first use, a capillary preconditioning was performed by rinsing 
the capillary with consecutively 1.0 M NaOH, 0.1 M NaOH, ultra-pure water, and BGE at a 
pressure of 1 bar during 20 min (3.28 µL min
-1
), each corresponding to about 55 capillary 
volumes.  
The CZE BGE composition after optimization was 800 mM formic acid and 800 mM acetic 
acid at a pH of 2.2. Methanol and isopropanol were used as organic modifiers in the BGE and 
the sheath liquid. The BGE was prepared weekly as all stock solutions, filtered through a 
0.25 µm syringe filter (Minisart® RC25, Sartorius, Goettingen, Germany) and placed during 
10 min in an ultra-sonic bath prior to CE experiments.  
For the PVA coating, the capillaries were prepared according to Belder’s protocol [41]. First, 
the capillary was filled with an acidified aqueous glutaraldehyde solution (200 mL of a 50% 
aqueous solution mixed with 300 mL of 1:10 diluted conc. HCl). Then, an acidified PVA 
solution (450 mL of a 5% aqueous PVA solution, mixed with 50 mL of 1:1 H2O diluted HCl) 
was pumped through the capillary at approximately 1 bar for 5 min. Then, the capillary was 
put in the gas chromatograph oven, heated from 40 to 160°C at 6°C min
-1
, and held at 160°C 
for 10 min with a nitrogen flow. 
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Between runs, the capillary was rinsed during 2 min with acetic acid (1 M) and 3 min with 
BGE both at a pressure of 1 bar (corresponding to 6-8 capillary volumes). The sample was 
injected hydrodynamically at 50 mbar during 20 s leading to an injection volume of 102 nL. 
The sample consisted of 500 µg ml
-1
 r-hCG in H2O. The sample injection was followed by a 
BGE plug injection at 50 mbar during 20 s. 
 
2.2.4 CZE-(TQ) MS method 
The CE-ESI-MS experiments were performed with an Agilent G7100 instrument utilizing an 
uncoated fused silica capillary with identical dimensions and from the same batch as during 
the CE-UV experiments. An Agilent CE ESI-MS sprayer and a Nano LC-pump sending the 
sheath liquid (H2O/MeOH/FA 50:50:0.1) was used at a flow rate of 0.6 µL min
-1
. The 
ionization was operated in the positive mode and the measurements performed on the Agilent 
triple quad 6400 detector MS. The fragmentor voltage, capillary voltage, used m/z ranges, and 
the drying gas parameters are shown in Table 1. 
 
Table 1: Optimized parameters of the MS detection obtained for the r-hCG analysis by CZE-
(TQ)MS for low (m/z 100-1000) and high (m/z 1000-2000) masses.  
 
 
 
 
 
 
 
 
 
 
3. Results and discussion 
3.1 Gel-electrophoretic analysis of hCG  
The most conventional electrokinetic method used for the characterization of proteins is gel 
electrophoresis. It is based, in general, on the use of SDS to unfold the proteins: the SDS 
molecules interact with the protein all along the amino acid-based chain and confer a constant 
charge-to-size ratio to all proteins. Therefore, they all have the same electrophoretic mobility 
and migrate across the gel according to their size.  
Different isoforms of dimeric hCG were detected using the SDS-PAGE technique [27, 28, 
30]. As reported, for example, by Gam and Latiff [28], many hCG bands were observed with 
main apparent MWs around 43.5 kDa and 38.5 kDa. Notice that it is only possible to give 
apparent MWs. Indeed, hCG is a highly glycosylated protein and the glycan content alters the 
Mass range (m/z) 100-1000 1000-2000 
Voltage fragmentor (V) 380 135 
Voltage capillary (V) 3000 5500 
Drying gas N2 N2 
Temperature (°C) 300 300 
Flow (L/min) 11 11 
Pressure (Psi) 15 15 
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hCG mobility in gel electrophoresis, because (i) the SDS molecules do not interact with the 
glycan moieties and, (ii) the glycan moieties can have a charge if they contain, for example, 
sialic acids. This is why the glycan moieties confer an additional electrophoretic contribution 
to that of the protein, which may decrease or increase its total apparent electrophoretic 
mobility. This explains why some authors observed what they called abnormal migration 
shifts in some cases when they implemented successive digestions with different enzymes to 
remove gradually the glycans from hCG [27].  
To overcome this limitation, Magnelli et al used a glycoprotein standard ladder (Candy-Cane 
from Invitrogen) [27]. However, it cannot lead to a correct MW determination as the glycan 
content of the standard glycosylated proteins may be dramatically different in nature (size) 
and charge from that of the hCG, that may be itself composed of various glycoforms with 
some of them being highly sialylated. Therefore, gel electrophoresis leads to apparent MWs 
of the hCG isoforms, but allows the comparison of different hCG profiles and can be helpful 
for the optimization of some protein treatment steps, such as their reduction.  
In this study, the SDS-PAGE technique was used to test different conditions of reduction of 
hCG using r-hCG as standard. The results are shown in Figure S1. Whatever the used 
percentage of β-mercaptoethanol between 2.5 and 7.5% at 95°C, a reduction time of 3 min 
was insufficient to completely reduce hCG. Using a longer reduction time of 15 min, two 
large bands were detected around 25-30 kDa that may correspond to the hCGβ isoforms, and 
one large band close to 18-20 kDa, which could be assigned to different isoforms of hCGα. 
Only with the harshest tested conditions, 7.5% of β-mercaptoethanol heated at 95°C for 
15 min, the hCG protein was totally dissociated into its subunits hCGα and hCGβ. 
 
 
Figure S1: Study of the reduction conditions on r-hCG by SDS-PAGE. Lane 1: protein 
molecular weight markers; lane 2: not reduced r-hCG; lane 3: 2.5% β-mercaptoethanol at 
95°C during 3 min; lane 4: 2.5% β-mercaptoethanol at 95°C during 15 min; lane 5: 5% β-
mercaptoethanol at 95°C during 3 min; lane 6: 5% β-mercaptoethanol at 95°C during 15 min; 
lane 7: 7.5% β-mercaptoethanol at 95°C during 3 min; lane 8: 7.5% β-mercaptoethanol at 
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95°C during 15 min. The arrows indicate the different isoforms of hCGα and hCGβ. The 
SDS-PAGE was performed using a 12% polyacrylamide gel and using vertical gel apparatus 
(Amersham® ECL® Gel Box, GE Healthcare, Aulnay-sous-Bois, France) at a constant 
voltage of 160 V during 60 min. The r-hCG sample was prepared by a two times dilution with 
Tris-HCl-SDS buffer. 0.5 µg of r-hCG sample was loaded per well. 
 
Next, for the first time for hCG, a high-performance capillary gel electrophoresis method was 
applied to separate the hCG isoforms. This was done with two hCG-based drugs, Ovitrelle® 
(r-hCG) and Pregnyl® (u-hCG). Figure 1 presents the resulting electropherograms. A protein 
MW standard mixture containing 7 recombinant proteins within the range of 10 to 225 kDa 
was used, not only to get calibration curves by plotting the MW as a function of the mobility 
(calibrations curves not shown) but mostly to evaluate the performance of the used analytical 
conditions (Figure 1A). It is obvious compared to SDS-PAGE (Figure S1, lane 1) that CGE 
provides improved resolutions with a shorter analysis time and a reduced sample 
consumption.  
 
 
Figure 1: Analysis by CGE-UV of r-hCG and u-hCG after a partial reduction. (A) Protein 
MW standard mixture; (B) r-hCG, with a zoom between 10 and 14 min (1), and between 16 
and 22 min (2); (C) u-hCG; and (D) overlay of the r-hCG and u-hCG electropherograms 
between 16 and 23 min. BSA was added as an internal standard in all samples. r-hCG and u-
hCG: 2 mg mL
-1
.Other conditions: see experimental section 2.2.1. 
 
Figure 1B presents the resulting electropherogram obtained with r-hCG after a partial 
reduction step (5% of β-mercaptoethanol heated at 95°C for 3 min). A large number of peaks 
were detected between 16 and 22 min (peaks 4 to 9), which may correspond to the time 
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window expected for the hCG isoforms having MWs between 30 and 50 kDa, considering a 
potential shift in migration time due to glycan moieties on hCG. This confirms the high 
complexity of hCG, which did not appear so clearly from the previous SDS-PAGE analysis. 
From the calibration curve, the apparent MW ranges of all main peaks were estimated 
considering the beginning and the end of each peak (Table 2), after calculating standard 
deviations on the apparent MWs, inferior or equal to 12 Da (n=3). As expected from the 
partial reduction conditions used before injection, some peaks that may correspond to hCGα 
isoforms (MW without glycan: 10,198 Da) and hCGβ (MW without glycan: 15,521 Da) were 
detected at the beginning of the electropherogram (peaks 1 and 2 for hCGα and peak 3 for 
hCGβ). Figure 1B shows also two peaks with apparent MWs higher than 80 kDa (peaks 10 
and 11), which may correspond either to highly-glycosylated hCG isoforms or to hCG 
aggregates. 
A hCG-based drug obtained after extraction from urine of pregnant women, u-hCG, was next 
analysed by CGE-UV in the same conditions, including the same partial reduction step. The 
resulting electropherogram is presented on Figure 1C. As expected since u-hCG is produced 
from complex biological samples, the corresponding electropherogram is much more 
complex, with additional peaks between 10 and 14 min compared to the r-hCG 
electropherogram. These peaks (1 to 5) correspond to apparent MWs values between 6,300 
and 9,780 Da that all are inferior to the MW of the α-subunit, even without any glycan. It can 
therefore be assumed that these peaks may correspond to either (i) other urinary proteins, (ii) 
cleaved forms of u-hCG, and/or (iii) highly sialylated hCGα. This last hypothesis is based on 
the fact that the presence of a high number of sialic acids on glycan moieties should accelerate 
the migration of the protein through the gel thanks to an additional anodic electrophoretic 
mobility contribution, and that some authors already observed a higher fraction of acidic hCG 
isoforms in urine [29, 42]. As previously discussed with r-hCG, the peaks 6, 7, and 8 can be 
assigned with a high level of confidence to the isoforms of the α-subunit and the peak 9 to one 
of the β-subunit. Figure 1C also shows a wide and quite intense massif of peaks eluting within 
the same range of migration times (16-22 min) as those of r-hCG. They should correspond to 
the u-hCG isoforms. Then, the peaks 13 and 14 in u-hCG (see Figure 1D for the enlarged 
view) were also detected with apparent MWs above 70 kDa, which may again correspond 
either to aggregated or highly glycosylated hCG.  
Finally, the most important result obtained by CGE analysis of both hCG-based drugs appears 
on Figure 1D, where the electropherograms were overlaid in the area of interest, 
corresponding to the hCG isoforms. Two different profiles appear, with a varying number of 
peaks, different migration times and intensities. This clearly demonstrates that both hCG-
based drugs contained isoforms, different in nature and amount. This study constitutes the 
first demonstration that CGE can be a useful and high performance technique for hCG 
fingerprinting. Nevertheless, CGE suffers from a big drawback: its incompatibility for a direct 
coupling with mass spectrometry, preventing further identification of the separated isoforms. 
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Table 2: Apparent MW range (determined as the estimated MWs at the beginning and end of 
each peak) and signal-to-noise ratio (S/N) of the main peaks seen in the CGE-UV analysis of 
r-hCG and u-hCG (u-hCG and r-hCG: 2 mg mL
-1
). For peak number: see Figures 1B, 1C and 
1D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2 CIEF-UV method 
A second electrokinetic technique usually involved in protein characterization is based on 
isoelectric focusing allowing a separation according to pI values. It has already been used at 
conventional format for hCG, to compare its isoforms in urine and serum samples [29, 30]. 
The obtained pI values were in the acidic range, between 3 and 7 in one case [29] and 3.3 and 
4.9 in the second [30]. For the first time, the capillary format (CIEF) was used here for hCG 
in order to improve significantly the resolution, as it can distinguish two proteins whose pI 
differ by as few as 0.005 pH units and allows determining of protein-charge heterogeneity 
profiles [23].  
For the CIEF analysis of hCG, 5 isoelectric pI markers with values between 4.1 and 10.0 were 
selected and analysed using a CIEF kit and an ampholyte 3-10 (Figure 2A). During the 
focusing step of 15 min, some pre-peaks were detected thus confirming the success of this 
 
r-hCG  u-hCG 
Peak 
number 
MW range (kDa) S/N 
Peak 
number 
MW range (kDa) S/N 
1 10.25-10.56 20 1 6.30-7.18 1500 
2 11.27-11.58 5 2 7.97-8.20 66 
3 18.77-19.58 7 3 8.35-8.66 100 
4 32.42-33.62 6 4 8.81-9.18 166 
5 37.48-41.80 211 5 9.28-9.78 366 
6 42.37-45.45 44 6 10.28-11.09 133 
7 47.91-50.98 34 7 11.39-12.36 400 
8 59.43-61.87 65 8 12.36-12.88 446 
9 64.01-66.24 80 9 19.13-29.03 80 
10 85.48-90.04 70 10 32.87-45.43 215 
11 90.30-101.61 77 11 49.03-52.87 466 
   12 53.66-61.27 10 
   13 73.22-78.41 750 
   14 78.41-99.00 1600 
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step. A chemical mobilisation step was next involved from 15 to 45 min, which displays the 
different pI marker peaks. The calibration curve was plotted, reporting the migration time and 
the pI marker values (Figure 2B). During the CIEF study, a calibration curve was built for 
each acquisition. However, the pI marker at 4.1 was not added in the preparation for the 
experiments because it would have co-migrated with some hCG isoforms.  
 
 
Figure 2: Analysis of r-hCG and u-hCG by CIEF-UV. (A) CIEF analysis of 5 pI markers, (B) 
Calibration curve, (C) CIEF analysis of r-hCG, and (D) overlay CIEF electropherograms of r-
hCG and u-hCG in a reduced time range (marker 4.1 added only in the u-hCG sample). r-hCG 
and u-hCG: 2 mg mL
-1
. Other conditions: see experimental section 2.2.2. 
 
First, r-hCG was mixed with the different pI markers, the cathodic and anodic stabilizers, the 
ampholytes providing a pH gradient between 3 and 10, and the CIEF gel containing 6 M urea.  
After the focusing and mobilisation steps, one typical resulting electropherogram is shown in 
Figure 2C. At least 15 r-hCG isoforms with pI values between 3.0 and 5.5 were separated. 
Table 3 presents the RSDs calculated for the migration times by taking the apex of the main 
peaks (n=3). They are between 0.92 and 1.23% for the migration times, which confirms the 
high repeatability of the CIEF method. With the calibrations curves, the corresponding pI 
values were determined, between 3.49 and 4.78, with RSD values below 1.55%. The results 
confirm the high resolution of the CIEF analysis for the characterization of protein isoforms, 
in particular hCG here, even if it is a very complex protein because of its 8 glycosylation 
sites.  
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Table 3: Relative standard deviation (RSD) values of the migration times and the estimated pI 
values of the main peaks obtained for the r-hCG analysis by CIEF-UV (n=3). r-hCG: 
500 mg L
-1
. For peaks number: see Figure 2C. 
 
Then, u-hCG was analysed by CIEF at the same conditions and Figure 2D presents an overlay 
in the area of interest of the resulting electropherogram with the one obtained for r-hCG. Two 
significantly different profiles can be observed, which confirms the previous result obtained 
in CGE that both hCG-based drugs contained isoforms, different in nature and proportion. 
Nevertheless, the u-hCG signal intensity is inferior to that of r-hCG. Two explanations can be 
provided. First, u-hCG is produced by extraction from urine and its bioactivity was 
determined to be 9,200 IU mg
-1
. Since each ampoule of drug contains 5,000 IU u-hCG, the 
calculation of the concentration in mg L
-1
 u-hCG was done considering that 1 IU was equal to 
0.092 [38, 43]. This calculation hypothesis may be inaccurate. Secondly, it is known that 
cleaved forms of hCG occur in urine and they may also be present in the u-hCG-based drug. 
These cleaved forms may still be bioactive and contribute to the lower intensities of the u-
hCG peaks with respect to the intensities of the r-hCG peaks, for which the concentration in 
mg L
-1
 is given by the manufacturer. Nevertheless, this experiment allows estimating a pI 
range between 4.5 and 5.2 for the u-hCG isoforms. This pI range, though somewhat narrower, 
is comparable to that obtained for r-hCG.  
 
3.3 CZE-UV 
Capillary zone electrophoresis involves a migration mechanism based on the charge and 
friction coefficient ratio of the molecule. It is particularly relevant for the separation of intact 
proteins, including the fingerprinting of intact isoforms [22, 44]. This is why this approach 
was implemented for hCG [34–37]. Nevertheless, as already mentioned in the introduction, 
three of the four papers involved a non-volatile borate- or phosphate-based buffer and UV 
detection preventing any identification [34–36]. To go further in the hCG isoform 
characterization, the hyphenation of the CZE separation with mass spectrometry (MS) is 
required, as it was done for the glycoform profiling of the intact hCGα [37]. 
Peak number 1 2 3 4 5 6 7 8 9 
tm (min) 34.08 34.54 34.79 34.95 35.15 35.83 36.29 36.80 37.32 
% RSD  1.23 1.22 1.22 1.23 1.20 0.92 0.87 1.02 0.99 
pI values 4.78 4.60 4.50 4.44 4.35 4.08 3.90 3.70 3.49 
% RSD 0.11 0.10 0.01 0.11 0.12 1.37 1.54 0.73 0.92 
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The optimization of the CZE-MS method for the hCG analysis first started with a simple UV 
detector for the sake of simplicity, but taking into consideration that the final purpose was the 
hyphenation of the CZE separation with an MS detection. Therefore, a long capillary length 
of 60 cm (effective length: 51.5 cm) and a volatile BGE were selected.  
Even if it was demonstrated that it was not possible to establish a generic CZE approach for 
the intact protein analysis and its transfer to CE-MS, two approaches are generally 
considered: working with a BGE at a pH either below or above the pI values of the proteins 
[45]. With a BGE pH below their pI values, proteins are positively charged and may interact 
with the deprotonated silanol groups at the surface of the capillary and, consequently, may 
adsorb more or less irreversibly, which is one of the main difficulties of protein analysis in 
CZE [22, 25, 45]. To limit this phenomenon, a capillary coating and/or a highly acidic pH can 
be used, to reduce as much as possible the deprotonation of the silanols and to favour the ESI-
MS ionization in positive mode. With a BGE pH above their pI values, proteins are negatively 
charged, as is also the capillary wall, and electrostatic repulsions may limit their adsorption. 
In previous works related to the CZE analysis of hCG, a bare fused-silica capillary and a BGE 
pH between 6 and 9 and containing some diaminoalkane were used [34, 35, 37]. At this pH 
range and according to the pI values previously observed in CIEF, the hCG isoforms are 
negatively charged, which should limit their interactions with the capillary surface.  
Thus, our first CZE experiments were carried out with a bare fused-silica capillary and a 
volatile BGE based on ammonium acetate at pH 8.0. It is worthwhile to note that the 
optimization of the parameters was done with r-hCG, which is purer than u-hCG. 
Unfortunately, a strong adsorption of hCG on to the capillary wall was observed, leading to 
peak broadening and low separation efficiencies. Different parameters were then tested to 
limit this phenomenon: an increase in the ionic strength from 50 up to 200 mM (maximum 
value allowing a voltage of 30 kV without detrimental Joule heating) by increments of 
50 mM, an increase in the separation temperature from 25 to 60°C with increments of 5°C, 
and the use of a HPC capillary coating as usually described in the literature [20, 22, 44, 46, 
47]. The best separation was obtained with a HPC-coated capillary, an ionic strength of 
200 mM and a temperature of 60°C as shown on Figure S2. In that case, 6 wide peaks were 
observed with a total analysis time of about 50 min. It was highly probable that each peak 
corresponds to several glycoforms or other types of post-translational modifications, such as 
methylation, oxidation or amidation. 
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Figure S2: Electropherogram obtained for the r-hCG analysis by CZE-UV with a volatile 
basic BGE: 200 mM ammonium acetate at pH 8.0. HPC-coated silica capillary, 50 μm x 
60 cm (effective length: 51.5 cm). Hydrodynamic injection: 20 s, 50 mbar. Voltage: -30 kV. 
Temperature: 60°C. UV detection: 214 nm. r-hCG: 0.500 mg mL
-1
. 
 
For comparison, our second approach consists of using a highly acidic BGE as was reported 
for the CZE-MS analysis of hCGα (BGE composed of 2% acetic acid at pH 2.5, but without 
any motivation of this choice) [37]. With a BGE pH below the previously determined pI 
values, the hCG isoforms are positively charged. BGEs based on formic acid (FA) and acetic 
acid (AC) at pH 2.2 were selected as they are both MS compatible and classically involved in 
this kind of application [44]. The effects of the nature and the concentration of the acids, 
alone or mixed (keeping their concentration constant) were first studied with a high voltage 
(30 kV) and a high temperature (60°C). As illustrated on Figure 3A, their combination led to 
an increased number of peaks and improved resolutions. This option was thus selected. It can 
also be noticed that the use of the acid BGE provides a dramatic decrease by a factor 10 in the 
analysis time compared to the basic BGE, whereas a similar number of peaks was observed. 
The concentration of each acid in the BGE was next varied from 0.2 to 1.0 M (Figure 3B). No 
Joule heating even at 30 kV was observed, regardless the tested concentrations. The 
concentrations of 800 mM of both FA and AC led to the best resolution and the highest 
number of separated isoforms. Therefore, this high BGE concentration may also help to 
prevent protein adsorption. 
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Figure 3: Optimization of the CZE-UV separation of r-hCG. (A) Effect of the BGE 
composition. (B) Effect of the acid concentrations. (C) Comparison between the use of bare 
and PVA-coated capillaries. (D) Effect of MeOH addition in BGE (800 mM of AC and FA, 
pH 2.2). r-hCG: 0.5 mg mL
-1
. Other conditions: see experimental section 2.2.3. 
 
Nevertheless, the potential problem of protein adsorption was considered. The use of a neutral 
polyvinyl alcohol (PVA) coating was first evaluated (Figure 3C), but it led to an increased 
baseline drift and a decrease in resolution and sensitivity. A second strategy to limit hCG 
adsorption was the addition of an organic modifier to the BGE, as already reported [44, 45]. 
Indeed, the solvent may modify the zeta potential of the capillary surface, change the 
ionization state of the proteins and the silanol groups, reduce the hydrophobic interactions 
between the proteins and the wall, and change the protein conformation and solvation, which 
all may change the selectivity and reduce the adsorption. It may also favour the desolvation 
process in the ESI source. Both isopropanol and MeOH were tested at 10, 20, and 30%. 
Concerning the use of isopropanol as organic modifier, no improvement of the separation was 
seen. In return, the addition of 20% MeOH led to the best sensitivity and resolution (Figure 
3D). The final BGE composition was thus 800 mM FA, 800 mM AC, and 20% MeOH, which 
led to the detection of 8 peaks within 8 min.  
 
3.5 CZE-MS 
The conditions optimized in CZE-UV were used for the hyphenation to a Triple Quadrupole 
mass spectrometer with an ESI interface and a nano-LC pump delivering a sheath liquid. Two 
different strategies for MS detection were used during this study: a detection targeting a low 
mass range (100-1000 m/z) and one targeting a high mass range (1000-2000 m/z). Both 
strategies needed an individual optimization. The conditions were first optimized for the low 
mass range. The fragmentor voltage was varied from 135 to 380 V, while keeping all other 
MS parameters constant. The highest sensitivity was obtained with a fragmentor voltage value 
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of 380 V. While maintaining the fragmentor voltage at 380 V, the capillary voltage of MS 
was varied from 0.5 to 6 kV. Some peaks appeared on the Base Peak Electropherogram (BPE) 
from a value of 2 kV and the maximum sensitivity was achieved at 3 kV. For the high mass 
range, a low fragmentor voltage of 135 V and a high capillary voltage of 5.5 kV were selected 
in order to avoid the fragmentation in the MS source and allow the transfer of the heaviest 
ions for the detection of intact isoforms. The retained MS parameters are summarized in 
Table 1. 
These two sets of parameters were used for the analysis of r-hCG. Figure 4A shows the 
corresponding BPE with the MS conditions adapted to the low mass range. Using a classical 
sheath liquid consisting of H2O-IPA (1/1) and 0.01% FA, at least 10 peaks were observed 
with an analysis time below 5 min. The decrease in analysis time, while increasing the 
separation length from the previous effective length in UV (51.5 cm) to the total capillary 
length in MS (60 cm), may come from small variations in the low electroosmotic velocity and 
from some suction effect [48]. The relative standard deviation values for the migration times 
and the intensities are summarized in Table 4 and are all inferior to 1.1% and 3,0%, 
respectively (n= 3), demonstrating a good repeatability of the CZE separation with at low 
mass range conditions of MS detection.  
 
Table 4: Relative standard deviation (RSD) values of the migration times and the relative 
intensity of 4 main peaks obtained for the r-hCG analysis by CZE-(TQ)MS with the 
optimized MS conditions for the low mass range (n=3). Other conditions and peak numbers: 
see Figure 4A. r-hCG: 500 mg L
-1
. 
 
 
Figure 4B shows the resulting MS spectrum obtained for peak 4 (between 3.75 and 3.83 min). 
It allows identifying some fragment ions corresponding to monosaccharides, such as galactose 
(Gal, m/z 163 Da) , mannose (Man, m/z 163 Da), acetylneuraminic acid (NeuAc, m/z 
292 Da), and acetylglucosamine (GlcNAc, m/z 204 Da) and some combinations. These 
monosaccharides confirm the presence of glycan chains on the glycoprotein. However, no 
detection of intact isoforms is possible within the targeted mass range.  
 
Peak number 1 2 3 4 
RSD(tm) (%) 0.96 0.95 0.98 1.02 
RSD (Relative intensity) (%) 1.61 1.35 2.17 3.00 
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Figure 4: CZE-MS analysis of r-hCG with the MS parameters for the low-mass range (100-
1000 m/z). (A) Base Peak Electropherogram (BPE). (B) MS spectrum between 3.75 and 
3.83 min (peak 4) on the BPE with the different diagnostic ions. r-hCG: 0.5 mg mL
-1
. Other 
conditions: see experimental section 2.2.4 and Table 1. 
 
Therefore, r-hCG was next analysed by CZE-ESI-MS applying the high-mass range MS 
conditions. With the parameters of sheath liquid used above (H2O-IPA (1/1) + 0.01% FA), the 
obtained BPEs at the high-mass range MS conditions were non-repeatable and without 
isotopic profiles. However, it is well-known that the composition of the sheath liquid has a 
strong impact on the ionization process [22, 49]. This is why the sheath liquid composition 
was modified in order to improve the efficiency and repeatability of the ionization step. 
Moreover, the Triple Quadrupole (TQ) MS has a low maximum mass-to-charge ratio, namely 
2000 m/z, which is rather low for the analysis of intact proteins. One of our purposes was thus 
also to increase as much as possible the ionization state charge of the hCG isoforms to 
decrease their m/z values.  
Therefore, the percentage of FA in the sheath liquid was varied from 0.01 to 0.5%. An 
increase in sensitivity was observed at 0.1% (see Figure S3 in supplementary data), but still 
no repeatable electropherograms were obtained. In a second approach, the nature of the sheath 
liquid was altered from H2O-IPA to H2O-MeOH, while maintaining 0.1% FA and a ratio of 
1/1. It led to an increased charge state and thus reduced m/z values and repeatable isotopic 
massifs in the 1000-2000 m/z range. Finally, the sheath-liquid flow rate was optimized as it is 
also known that this parameter affects the ionization process [49]. It was varied from 0.2 to 
1.0 µl min
-1
. While applying a flow rate of 0.6 µl min
-1
, a stable spray and repeatable 
migration times were obtained with these MS parameters for the high-mass range (1000-
2000 m/z).  
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Figure S3: Effect of FA percentage in the sheath liquid on the BPEs obtained from r-hCG by 
CZE-MS for the high-mass range (1000-2000 m/z). r-hCG: 0.5 mg mL
-1
. Other conditions: 
see experimental section 2.2.4 and Table 1. 
 
After optimization of the sheath liquid, the resulting r-hCG BPE showed at least 12 peaks 
between 4.25 and 5.01 min, corresponding to hCG isoforms with different glycosylations or 
PTMs (Figure 5A). It is worthwhile to notice the difference in migration times with the CZE 
separation obtained at the low mass range MS conditions (3.08-4.25 min, see Figure 4A). This 
is probably due to the different composition (H2O/MeOH/FA) of the sheath liquid, which can 
induce a suction effect.  
These conditions were also used for the analysis of u-hCG, in order to evaluate the potential 
of this approach to distinguish some differences between the two drugs (Figure 5B). The 
separation profile showed two elution zones, the first one between 3.76 and 4.05 min, and the 
second one between 4.24 and 5.45 min, but the resolution is not insufficient here to 
distinguish individual peaks, probably due to the high complexity of the u-hCG sample.  
Figures 5C and 5D present the MS spectra between 4.24 and 5.01 min on the BPEs for r- and 
u-hCG-based drug, respectively. The m/z values corresponding to hCG isoforms of r-hCG are 
mainly comprised between 1500 and 1900, with three intense peaks at m/z 1530.6, 1562.2, 
and 1595.0. With u-hCG, the mass range of isoforms is different with m/z values comprised 
between 1400 and 1650. The differences between the two MS profiles confirm clearly the 
presence of different isoforms in each hCG-based drug, which probably results from their 
different sources of production (recombinant or extracted from the urine of pregnant women). 
Nevertheless, the identification of the r- and u-hCG isoforms is impossible due to the low 
resolution of the triple quadrupole MS detector. Indeed, the analysis of glycoproteins such as 
hCG with 8 glycosylation sites, requires an MS detector with a higher resolution, such as a 
quadrupole/time-of-flight (QTOF), to obtain the isotopic profiles of each isoform allowing a 
correct spectrum deconvolution for their identification. However, this CZE-(TQ)MS strategy 
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is very promising for fingerprinting to compare different batches of a given hCG drug or 
different hCG-based drugs. 
 
 
Figure 5: CZE-MS analysis of r-hCG and u-hCG with the MS parameters for the high-mass 
range (1000-2000 m/z). Base Peak Electropherograms (BPE) of (A) r-hCG and (B) u-hCG. 
Mass spectra between 4.24 and 5.01 min on the BPEs of (C) r-hCG and (D) u-hCG. r-hCG 
and u-hCG: 0.5 mg mL
-1
. Other conditions: see experimental section 2.2.4 and Table 1. 
 
 
Conclusion 
 
In order to better characterize the heterogeneity of hCG, its analysis at the intact level by 
different high-performance capillary electrokinetic techniques (CGE-UV, CIEF-UV, CZE-
UV, and CE-ESI-MS) was undertaken for the first time. This study confirmed the very high 
heterogeneity of hCG isoforms, leading to different pI and electrophoretic mobility values. 
After optimization of several experimental parameters, the CZE-MS analysis with a Triple 
Quadrupole detector demonstrates, for the first time, its potential for a fingerprinting approach 
as it allows to differentiating the two hCG-based drugs. In addition, this method is fast and 
cheap, compared to conventional bottom-up approaches. Therefore, a full validation of this 
method seems to be relevant as a perspective for this work. Finally, the conditions of the CZE 
method can be used for the hyphenation with a high-resolution mass spectrometer, such as a 
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QTOF, which should be helpful for the identification of the different isoforms (glycoforms 
and other PTMs). 
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